Deutsche Bank Starts Regeneron Pharma (REGN) at Hold
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Regeneron Pharma (REGN) PT Raised to $915 at DZ Bank
November 6, 2023 4:58 AM ESTDZ Bank analyst Elmar Kraus raised the price target on Regeneron Pharma (NASDAQ: REGN) to $915.00 (from $876.00) while maintaining a Buy rating.... More
